Raphael Mechoulam Selected Research

Inflammation (Inflammations)

12/2022	A Fenchone Derivative Effectively Abrogates Joint Damage Following Post-Traumatic Osteoarthritis in Lewis Rats.
9/2021	Novel CBG Derivatives Can Reduce Inflammation, Pain and Obesity.
1/2020	Beyond THC and Endocannabinoids.
10/2018	Bioactive lipids ALIAmides differentially modulate inflammatory responses of distinct subsets of primary human T lymphocytes.
1/2017	Cannabidiol attenuates alcohol-induced liver steatosis, metabolic dysregulation, inflammation and neutrophil-mediated injury.
9/2016	Cannabidiol Limits T Cell-Mediated Chronic Autoimmune Myocarditis: Implications to Autoimmune Disorders and Organ Transplantation.
1/2016	HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells.
4/2012	A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.
5/2011	Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
12/2010	Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raphael Mechoulam Research Topics

Disease

19	Nausea 12/2023 - 04/2002
16	Inflammation (Inflammations) 12/2022 - 12/2004
14	Neoplasms (Cancer) 12/2023 - 03/2003
12	Vomiting 02/2022 - 03/2003
9	Pain (Aches) 01/2023 - 12/2004
7	Schizophrenia (Dementia Praecox) 01/2022 - 01/2007
7	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 12/2005
7	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019 - 10/2009
6	Infarction (Infarctions) 01/2019 - 08/2003
6	Multiple Sclerosis 01/2016 - 04/2006
5	Closed Head Injuries 01/2019 - 04/2005
5	Parkinson Disease (Parkinson's Disease) 08/2011 - 08/2003
4	Cognitive Dysfunction 01/2022 - 08/2007
4	Obesity 09/2021 - 01/2007
4	Epilepsy (Aura) 01/2020 - 01/2007
4	Osteoporosis 10/2019 - 01/2007
4	Neuroinflammatory Diseases 01/2019 - 05/2008
4	Huntington Disease (Huntington's Disease) 02/2013 - 01/2007
4	Hepatic Encephalopathy 09/2009 - 01/2006
3	Wounds and Injuries (Trauma) 01/2023 - 07/2008
3	Catalepsy 01/2023 - 10/2017
3	Hypothermia 01/2023 - 10/2017
3	COVID-19 10/2022 - 01/2021
3	Neuralgia (Stump Neuralgia) 01/2022 - 01/2020
3	Infections 01/2021 - 12/2018
3	Fibrosis (Cirrhosis) 09/2016 - 09/2009
3	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2016 - 05/2008
3	Reperfusion Injury 01/2016 - 05/2011
3	Liver Diseases (Liver Disease) 09/2009 - 01/2006
2	Substance-Related Disorders (Drug Abuse) 10/2023 - 01/2023
2	Osteoarthritis 01/2023 - 12/2022
2	Mental Disorders (Mental Disorder) 01/2023 - 05/2010
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2022
2	Tobacco Use Disorder (Nicotine Dependence) 09/2020 - 01/2019
2	Body Weight (Weight, Body) 02/2020 - 03/2005
2	Sleepiness 01/2019 - 05/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2016 - 12/2007
2	Ischemia 01/2016 - 05/2011
2	Experimental Arthritis 10/2015 - 03/2004

Drug/Important Bio-Agent (IBA)

45	CannabinoidsIBA 12/2023 - 02/2002
37	CannabidiolIBA 12/2023 - 04/2002
26	EndocannabinoidsIBA 10/2023 - 02/2002
10	Dronabinol (THC)FDA LinkGeneric 01/2023 - 01/2004
7	Lithium ChlorideIBA 12/2023 - 04/2002
7	cannabidiolic acidIBA 12/2023 - 07/2017
7	AntiemeticsIBA 02/2022 - 07/2004
6	Cannabinoid Receptors (Cannabinoid Receptor)IBA 12/2022 - 02/2007
6	Messenger RNA (mRNA)IBA 01/2021 - 05/2006
6	Glycerol (Glycerine)FDA LinkGeneric 05/2016 - 02/2002
5	HU 308IBA 01/2023 - 12/2008
5	AmidesIBA 02/2022 - 10/2018
5	CB2 Cannabinoid ReceptorIBA 01/2022 - 08/2009
5	EstersIBA 01/2021 - 01/2018
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 07/2008
5	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2019 - 01/2004
5	Cannabinoid Receptor AgonistsIBA 01/2016 - 02/2002
5	Neuroprotective AgentsIBA 08/2011 - 02/2002
5	LithiumIBA 02/2008 - 03/2003
4	anandamide (arachidonylethanolamide)IBA 06/2022 - 02/2002
4	Morphine (MS Contin)FDA LinkGeneric 02/2022 - 02/2020
4	Fatty Acids (Saturated Fatty Acids)IBA 02/2022 - 01/2019
4	muskIBA 02/2022 - 01/2004
4	Naloxone (Narcan)FDA LinkGeneric 02/2022 - 02/2020
4	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022 - 02/2013
4	quinone (benzoquinone)IBA 03/2021 - 07/2004
4	cannabidiol hydroxyquinone (HU331)IBA 03/2021 - 07/2006
4	Serine (L-Serine)FDA Link 10/2019 - 06/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017 - 02/2002
3	Alanine (L-Alanine)FDA Link 12/2023 - 09/2020
3	Therapeutic UsesIBA 10/2022 - 09/2009
3	Medical MarijuanaIBA 01/2022 - 01/2018
3	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 02/2013
3	HU-910IBA 01/2022 - 04/2012
3	N-oleoylglycineIBA 01/2021 - 01/2020
3	5-HT1A Serotonin ReceptorIBA 09/2020 - 06/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 07/2006
3	AM 251 (AM251)IBA 01/2019 - 04/2012
3	3-nitrotyrosineIBA 01/2017 - 05/2011
3	CytokinesIBA 10/2015 - 05/2006
3	AntioxidantsIBA 02/2013 - 01/2004
3	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 05/2011 - 04/2005
3	EmeticsIBA 01/2006 - 04/2002
2	Analgesics (Analgesic Drugs)IBA 12/2022 - 01/2006
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 02/2022 - 09/2020
2	Amphetamine (Amfetamine)FDA LinkGeneric 01/2022 - 01/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2022
2	Calcium Gluconate (CBG)IBA 09/2021 - 06/2011
2	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2020
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2019
2	HU-580IBA 09/2020 - 01/2018
2	Serotonin (5 Hydroxytryptamine)IBA 09/2020 - 08/2003
2	SaccharinIBA 09/2020 - 06/2011
2	Methylazoxymethanol AcetateIBA 01/2020 - 01/2019
2	LipidsIBA 10/2018 - 08/2011
2	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2018 - 06/2011
2	Transaminases (Aminotransferases)IBA 01/2017 - 05/2011
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2015 - 05/2011

Therapy/Procedure

10	Therapeutics 01/2022 - 07/2006
8	Drug Therapy (Chemotherapy) 12/2023 - 04/2002
3	Ovariectomy (Oophorectomy) 10/2019 - 10/2010